A whitepaper from MMIT provides information on value assessments and insight into market access for gene and cell-based therapies. MMIT utilizes advanced analytical tools to provide market access insights.
“How do payers value a treatment that slows down a disease vs. silencing it or even curing it? The rise of cell and gene therapies means that payers need more information than ever to properly assess treatments.” Learn more about MMIT’s analytical tools and download the article today.
(Source: MMIT, 2021)
